Eliav Barr
Fortuna: 2 M $ al 31/08/2026
Fortuna: 2 M $ al 31/08/2026
Eliav Barr is currently an Independent Director at Veracyte, Inc. since 2022.
Dr. Barr is also the Chief Medical Officer at Merck Research Laboratories Massachusetts LLC since 2022.
Dr. Barr completed undergraduate studies at The Pennsylvania State University and earned a doctorate from Sidney Kimmel Medical College.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
VERACYTE, INC. 0,07 % | 11/06/2026 | 56.461 ( 0,07 % ) | 2 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| VERACYTE, INC. | Director/Miembro de la Junta | 09/08/2022 |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Director Técnico/Científico/I+D | 01/04/2022 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Veracyte, Inc.
Veracyte, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes diagnostic products & biopharmaceutical services | Health Technology |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Sidney Kimmel Medical College
Sidney Kimmel Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.